Co-Diagnostics, Inc. CODX
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.28M | -9.14M | -25.75M | -5.89M | -7.73M |
| Total Depreciation and Amortization | 201.80K | 255.40K | 267.60K | 267.40K | 291.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 262.50K | 132.10K | 19.19M | 497.60K | 309.60K |
| Change in Net Operating Assets | -1.33M | 906.20K | 92.10K | -782.70K | -1.16M |
| Cash from Operations | -7.15M | -7.85M | -6.20M | -5.90M | -8.29M |
| Capital Expenditure | -18.30K | -142.00K | -132.00K | -75.10K | -401.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -150.00K | -- | -197.50K | 2.25M | 17.47M |
| Cash from Investing | -168.30K | -142.00K | -329.40K | 2.17M | 17.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.74M | 4.33M | 6.97M | 4.06M | 429.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.74M | 4.33M | 6.97M | 4.06M | 429.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.58M | -3.65M | 440.70K | 328.80K | 9.21M |